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Abbott's Fluorescence Polarization Immunoassay for Cyclosporine and Metabolites Compared 
with the Sandoz "Sandimmune" RIA 
Ajit Sanghvi,1 Warren Diven,' Howard Seltman,' and Thomas Starzl2 
A new procedure for measuring cyclosporine in plasma has 
been introduced by Abbott Laboratories, involving their TDx 
instrumentation and fluorescence polarization immunoassay. 
Radioimmunoassay (RIA) and high-performance liquid chro-
matography are currently the conventional methods for mea-
suring cyclosporine in plasma and whole blood. In an effort to 
find a method that will decrease the radioactive hazard, the 
reagent and supply cost, and the labor requirements associ-
ated with RIA procedures, we used specimens from trans-
plantation patients to compare the Abbott assay with the 
Sandoz Sandimmune' assay. We believe that the Abbott 
assay offers some advantages over the Sandimmune RIA 
procedure, providing a reliable but simpler and less hazard-
ous technology. 
The increase in organ transplantation and in patients 
receiving cyclosporine as part of immunosuppressive thera-
py has caused a dramatic increase in the number of labora-
tory requests for its assay (1). The two technologies common-
ly used to evaluate cyclosporine are high-performance liquid 
chromatography (HPLC) and radioimmunoassay (RIA). Ab-
bott Laboratories has recently introduced an assay that 
measures cyclosporine and its metabolites by fluorescence 
polarization immunoassay (FPIA), with the "TDx" instru-
mentation (2). 
At the University of Pitfsburgh School of Medicine, 4000 
patients' specimens per month are analyzed in duplicate by 
the Sandoz "Sandimmune" assay for cyclosporine. The 
method measures the drug and some fraction of metabolites 
in either plasma or whole blood. A competitive protein-
binding ligand procedure, the Sandimmune RIA involves 
use of a tritiated antigen, which requires liquid scintillation 
spectrometry. The combination of radiolabeled materials 
and complex analytical techniques results in a variety of 
practical concerns: (a) radioactive hazard to personnel; (b) 
disposal of low-level radioactive waste; (c) expense and 
storage of reagents and disposables; (el) need for highly 
trained technical staff; (e) increased labor intensity from 
multiple handling steps; (j) lengthy incubation and counting 
processes; Igi complex and costly instrumentation, requiring 
significant space accommodations; and (h) relatively poor 
precision . 
As the volume of cyclosporine analyses increases, the 
difficulties encountered in RIA procedures are magnified. 
We have evaluated the Abbott cyclosporine assay in order to 
more quickly provide results to clinicians and also to elimi-
nate radioactive reagents from the laboratory. We analyzed 
408 specimens along with more than 200 controls, in dupli-
cate, by both the Abbott FPIA TDx method and the Sandim-
mune RIA. Results of this study indicate that values for 
cyclosporine measured by the FPIA TDx are higher than 
those determined by the Sandimmune RIA. The TDx meth-
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od, however, is more precise, easier, and highly reliable. In 
addition to rapid result reporting, the method provides a 
simple technology with few handling steps, compact instru-
mentation, and few reagent storage and disposal problems. 
Materials and Methods 
Sample collection. Samples, collected from each patient 
into tubes containing EDT A as anticoagulant, were allowed 
to equilibrate for 2 h at room temperature, then plasma was 
separated from the cells at room temperature after centrifu-
gation. Temperature of the specimen during separation is 
an important factor, because the equilibration of cycJospor-
ine with erythrocytes is temperature dependent (3). No 
correction was made for hematocrit. 
Procedures 
RIA. Cyclosporine in plasma was measured by RIA with 
the Sandoz RIA kit according to the manufacturer's instruc-
tions (4). 
FPIA. Fluorescent polarization immunoassay with use of 
the Abbott TDx instrument is a recognized method for 
measurement of drugs and other constituents in body fluids 
(5-7). In the new procedure for cyclosporine, an antP iy is 
used that reacts both with cycIosporine and somt: A- its 
metabolites. We performed the assay according to the manu-
facturer's instructions. 
The concentration range of the Abbott calibrators is 0 to 
1000 ~/iK Specimens containing cycIosporine in concentra-
tions > 1000 JJ,g/L were diluted with the zero calibrator 
(normal human serum) before the precipitation step, as 
were also specimens with background intensity> 1000. The 
manufacturer does not recommend a change in the back-
ground (MX BKGl setting. 
Results 
Cross-reacticity and." 'ci(icity. We tested cross-reactivity 
with compounds listed in Table 1, whose concurrent ~ 
might interfere with the assay. Cross-reactivity was estab-
lIshed for a specimen by adding the test compound at a 
concentration of 100 mg/L, to drug-free pooled h~an 
serum, then assaying the specimen by the FPIA assay. The 
percentage cross-reactivity was calculated as: Eme~sured 
cycJosporine and metabolites concentration divided by the 
concentration of the test compound) x 100. The compounds 
tested were all below the detection limit of the assay 1<15 
~!iFK 
Precision. Precision studies were performed on the Abbott 
low-, medium-, and high-concentration control sera (Tablp 
2). All three control concentrations were included in ea,'l 
batch of 2(1. For the low control, 59 replicates were proc-
essed, yielding a coefficient of variation (CV) of 9.5% total 
and.7.4%- within-run; for the medium concentration, 60 
replIcates for a total CV of 4.9% and within-run CV of2.9%; 
for the hIgh concentration, 61 replicates with a total CV of 
4.4%- and within-run CV of 3.0%. 
Precision of patients'-sample and control duplicates was 
excellent. Of about 600 specimens analyzed, only 10 samples 
Table 1. Compounds Tested for Interference In the 
Abbott Cyclosporine Assay· 
Amikacin 
Ampicillin 
Azathioprine 
Carbamazepine 
Cephalosporin 
Chloramphenicol 
Cimetidine 
Digitoxin 
Digoxin 
Dipyridamole 
Disopyramide 
Encainide 
Erythromycin 
Ethosuximide 
Furosemide 
Gentamicin 
Kanamycin A 
Kanamycin B 
Ketoconazole 
lidocaine 
Methylprednisolone 
Neomycin sulfate 
Oxytocin 
Phenobarbital 
Phenytoin 
'Prednisone 
• Prednisolone 
Primidone 
Procainamide 
Propranolol 
Quinidine 
Spectinomyein 
Streptomycin 
Tobramyein 
Tocainide 
Triamterene 
Valproie acid 
Vancomycin 
Verapamil 
• These compounds were undetectable « 15 !L9IL) when tested up to 100 or 
'10 mglL. 
Table 2. Performance Statistics of the TDx 
Cyclosporlne Assay 
Precision 
Expected Determined (n = 59 to 61) 
Control 
range range Total Within-run 
(Abbott) mgll CV."'- cv."'-
Low conen 60-90 63-93 9.5 7.4 
Med. concn 225-275 219-267 4.9 2.9 
High conen 600-800 663-792 4.4 3.0 
had to be repeated because of duplication problems (duplica-
tion criterion: samples must duplicate within 5 net Polariza-
tion Units). 
Standard-curve stability. Three times during 20 days, 
fresh TDx standards were run in the TDx. Values consis-
tently fell within 5% of assigned values and none differed by 
more than 10%. 
Carryover. We saw no significant carryover from speci-
mens with high concentrations. 
Accuracy. Analytical recovery was tested with two sets of 
samples prepared by adding cyclosporine to give concentra-
tions of 50, 75, 100. 200, 250, 500, and 700 ~!i to normal 
human serum and to normal human serum diluted fivefold 
in TDx Dilution Buffer. The TDx analyzer was calibrated 
with serum-based calibrators provided by the manufacturer. 
Both sets of specimens were determined in replicates of five 
and the results compared with the calibration curve (Table 
3). The average analytical recovery from diluted serum was 
98.5% (SD 3.1%), from undiluted serum, 97.2% (SD 3.8%). 
Comparison of methods. We received 408 specimens with 
requests for cyclosporine assays. These were used in the 
correlation studies. Plasma samples were prepared and 
processed by both the Sandoz Sandimmune RIA procedure 
and Abbott's cyclosporine and metabolites FPIA assay. Each 
sample was analyzed in duplicate and the values were 
averaged. On linear regression analysis comparing the two 
sets of results, the equation for the regression line was 
determined to be (1.72 :t 0.045%) + (61.8 :t 4K4UF~I with 
a correlation coefficient of r = 0.884 (Figure 1). The standard 
error of the regression was 56.4. 
Table 3. Analytical Recovery of Cyclosporlne In the 
Abbott TDx Assay 
Expected Recovered from Recovered from 
concn diluted serum undll. serum 
I'9.'L Recovery, "'- ,.glL "'-
SO SO.4O 100.80 49.79 99.58 
75 75.15 100.20 71.39 95.19 
100 96.64 96.64 96.41 96.41 
200 197.53 87.77 202.98 101.49 
250 257.75 103.10 254.09 101.64 
500 479.SO 95.90 459.79 91.96 
700 660.43 94.35 657.32 93.90 
Discussion 
We found the Abbott TDx to be significantly more precise 
than the Sandimmune RIA. Coefficients of variation ranged 
from 4% to 10% for the TDx. Comparable values for the 
Sandimmune assay, which is in routine use in our labora-
tory, are 10% to 17%. 
When our HPLC or RIA standards were run in the TDx, 
the regression equation resulting from that comparison was 
TDx value = 0.92 [HPLC or RIA] value - 3.9, r = 0.9992. 
However, values for the TDx assay from patients' samples 
were about 1. 7 times the RIA values. This lack of correlation 
indicates that the two assays are not in fact measuring 
exactly the same thing. The Abbott antibody may react with 
a cyclosporine metabolite that is unreactive in the Sandoz 
assay system, or there may be a generally increased cross-
reactivity to all or to some subset of cyclosporine metabo-
lites. In either case we believe this offers an advantage for 
the TDx assay, because recent observations from this insti-
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Fig. 1. Comparison of cycIosporine values obtained by the Abbott TDx 
and Sandoz RIA methods 
Organ transplanted is as indicated: x. liver. D. heatt. <>. kidney 
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tllbll1l 11\1\1\'1111' Ihat ~DnFED cyclosporine metabolites-partic-1ff/1r1~D ~y" M I :\, ~" 7, M 18. and M21--possess immunosup-
pl"yD~"DyyDfD HI'II\ 1\\ :y~ dl'tnonslrated in vitro by use of lympho-
c~·tfDm"DftfiDf IIb"1I a~<lKK:KyssI Metabolites M17 and Ml in 
pm11\'1dar 1'\1 I I' ". . . 
\I 'I 1IIIIllunosuppresslve actlVlty 10 vItro ap-
pmHl'h"I" I h, • I ' h 
" .11 1''' .... l\ll'l.'<i by cyclosponne. Moreover, t ese 
1111'llIh .. ItI"I' lIl'l"':\\" to exhibit varying immunosuppressive 
pOII'I\l'\" dl'l .... ' 11.\ 11110: IIpon the T-cell clones used in the test 
",'''tl'llI \ ... "I) '\'\ ed 
'h' ' • , , WI"I'I1'\', the drug concentrations measur \' 11\1' [·'1 '\.\ . h 
' , a".<:\\" may more closely approxImate t e 
l~1feD1D"1 rallllll \,1' fml1lun~suppressive drug present in the 
cltnilnll '\'1 
till 11'''1' differences between the two assay sys-ttDflt~If"Dlypll .. 1 wIth tlw fact that there is greater imprecision 
wllh. tilt' H\.'\ Itwthnd, account for the observed correlation 
(,()('jlll"ll'1I1 III' (I 1"~q liS well as the greater scatter observed at 
hllo:h \'111111'11 
'1'11\'1"1' III'" h\'\1 poll'ntial problems with the TDx plasma cydIyf~f""DfD1f11D eII~yIyI \(]) Assay linearity of lOOO ~fi was not 
SUtlll'lt'ltt 11\ lillI' 11l1 .... lratory because about four to six sam-
pll'lI lit II I I'll\' IIf".!O neffied to be diluted. (b) With prolonged 
WI(', till' ilttq,1'I1 \' of the kit may be compromised because, 
O\'I'r 111111'.1'\11\( 1,\,1 values may exceed the high limit, possibly 
OWIIl" til u ,\. H 
" I~f III' 1'\'nporatlOn of the reagent. owever, we 
oh!'('\"\"'I1 II I 1 I . I . d ' lyt'cal \ "It ..... <llltla evaporatIOn unng an ana I 
run: 1'''"1,.,,[ yDlfhlyD~ at the beginning and end of several 
as"ff~D" WI'''' :2" /' • 9.6 and 243 ± 9.4 mglL (n = 24), 
rt's\x'l'1 1\'" I \" 
Th '1'1 h I' Ix \111'\ hod offers a simpler procedure with fewer 
I1l1dlllllo( sll'\ls lind fnl.'ter turnaround time. The instrumen-
tutlon il>l 1II11t1l\\altoci and compact, allowing better use of 
;SiMXk. £2£4 2 
Ikchnologist time and laboratory space. Reagents and sup-
plies present minimal storage and disposal problems and no 
radioactivity hazmd. 
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